Transfected or untransfected A549 and H446 cells were treated with or without 50 µM shikonin (Shanghai Yuanye Biotechnology Co., Ltd.) for 24 h at 37°C. Total RNA was extracted from clinical specimens or cells using TRIzol® reagent (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. Total RNA was reverse transcribed into cDNA using a PrimeScript RT kit (Takara Biotechnology Co., Ltd.), according to the manufacturer's protocol. qPCR was subsequently performed on an ABI 7500 Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.) using a SYBR® Premix Ex Taq™ kit (Takara Biotechnology Co., Ltd.). The following thermocycling conditions were used for the qPCR: Initial denaturation at 95°C for 3 min; followed by 40 cycles at 95°C for 5 sec and 60°C for 30 sec. The following primers pairs (Sangon Biotech Co., Ltd.) were used for the qPCR: PFKFB2 forward, 5′-GCTGCTTGGTGGGAGTGATAA-3′ and reverse, 5′-TGAGAAGCCAAGTGTCAGGG-3′; and β-actin forward, 5′-GAGGACCCTGGATGTGACAG-3′ and reverse, 5′-AAGACCTGTACGCCAACACA-3′. Relative mRNA expression levels were quantified using the 2−ΔΔCq method (27) and normalized to β-actin.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.